CommercialCoverageMedium impact
Gender Affirming Surgery and Treatments for Commercial and Medicare Advantage Members 7.01.84
Excellus BlueCross BlueShield·Plastic Surgery, OB-GYN, Urology +3 more·Miscellaneous
Effective date
May 21, 2026
We identified it
Jun 20, 2026
Summary
Excellus BlueCross BlueShield has established new comprehensive coverage criteria for gender-affirming surgeries and treatments for Commercial and Medicare Advantage members, including mastectomy, breast augmentation, genital reconstruction, voice therapy, and other procedures. The policy requires specific documentation including qualified professional letters, 6-month hormone therapy completion for most procedures, and detailed consent processes.
Action Required
By May 21, 2026: Billing team must update prior authorization workflows for gender-affirming procedures to require qualified professional letters documenting DSM-5-TR gender dysphoria diagnosis, 6-month sustained diagnosis, capacity to consent assessment, and procedure-specific criteria. Voice therapy (CPT 92507) requires Behavioral Health Medical Director review. Update encounter forms to capture required documentation elements. Claims without proper documentation will likely be denied.